Targeting Melanogenesis with Postbiotics: An Integrated Zebrafish-Based Assessment of

Gabor Katona, Natasa Jovanovic Ljeskovic, Ivana Strahinic, Nemanja Stanisavljevic, Sladjana Vojvodic, Jelena Djuris, Aleksandar Pavic

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Anti-Photoaging and Anti-Melanogenic Effects of a NovelJournal of microbiology and biotechnology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabor KatonaFaculty of Pharmacy Novi Sad, University Business Academy in Novi Sad, Heroja Pinkija 4, 21101 Novi Sad, Serbia.

Natasa Jovanovic LjeskovicFaculty of Pharmacy Novi Sad, University Business Academy in Novi Sad, Heroja Pinkija 4, 21101 Novi Sad, Serbia.

Ivana StrahinicInstitute of Molecule Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.

Nemanja StanisavljevicInstitute of Molecule Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.

Sladjana VojvodicFaculty of Pharmacy Novi Sad, University Business Academy in Novi Sad, Heroja Pinkija 4, 21101 Novi Sad, Serbia.ORCID 0000-0002-9772-3998

Jelena DjurisFaculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.ORCID 0000-0002-1833-6704

Aleksandar PavicInstitute of Molecule Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0003-3233-1341

Funding

The Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200042

6 · The paper itself

Abstract

Skin hyperpigmentation disorders represent a major dermatological challenge, and safe alternatives to conventional depigmenting agents remain scarce. Probiotics and their postbiotic derivatives have emerged as promising natural candidates; however, only a few bacterial strains have been investigated for melanogenesis-inhibitory activity, and their true potential remains largely unexplored. Here, we report for the first time the biosafety profile and anti-melanogenic activity of

Indexed as

HyperpigmentationLacticaseibacillus paracaseiLactobacillusMelaninsProbioticsAnimalsMelanocytesMelanogenesisZebrafishMelaninsLactobaccilus salivariusLactobacillus paracaseimelanocytes imagingmelanogenesiszebrafish

Identifiers

PMID41157150

DOI10.3390/molecules30204134

PMCPMC12567018

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.